Cite
Eder M, Neels O, Müller M, et al. Novel Preclinical and Radiopharmaceutical Aspects of [68Ga]Ga-PSMA-HBED-CC: A New PET Tracer for Imaging of Prostate Cancer. Pharmaceuticals (Basel). 2014;7(7):779-96doi: 10.3390/ph7070779.
Eder, M., Neels, O., Müller, M., Bauder-Wüst, U., Remde, Y., Schäfer, M., Hennrich, U., Eisenhut, M., Afshar-Oromieh, A., Haberkorn, U., & Kopka, K. (2014). Novel Preclinical and Radiopharmaceutical Aspects of [68Ga]Ga-PSMA-HBED-CC: A New PET Tracer for Imaging of Prostate Cancer. Pharmaceuticals (Basel, Switzerland), 7(7), 779-96. https://doi.org/10.3390/ph7070779
Eder, Matthias, et al. "Novel Preclinical and Radiopharmaceutical Aspects of [68Ga]Ga-PSMA-HBED-CC: A New PET Tracer for Imaging of Prostate Cancer." Pharmaceuticals (Basel, Switzerland) vol. 7,7 (2014): 779-96. doi: https://doi.org/10.3390/ph7070779
Eder M, Neels O, Müller M, Bauder-Wüst U, Remde Y, Schäfer M, Hennrich U, Eisenhut M, Afshar-Oromieh A, Haberkorn U, Kopka K. Novel Preclinical and Radiopharmaceutical Aspects of [68Ga]Ga-PSMA-HBED-CC: A New PET Tracer for Imaging of Prostate Cancer. Pharmaceuticals (Basel). 2014 Jun 30;7(7):779-96. doi: 10.3390/ph7070779. PMID: 24983957; PMCID: PMC4113732.
Copy
Download .nbib